🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well high-dose aldesleukin and ipilimumab w...
Status
Terminated
Location
Loyola University Medical Center
Start Date
2014-11-26
Trial ID
NCT02203604
Treatments Being Tested
This study is designed to evaluate efficacity and safety of everolimus or (...
Status
Completed
Location
CHU Amiens
Start Date
2009-03
Trial ID
NCT01028092
Treatments Being Tested
This study examines the use of denileukin diftitox (Ontak) for patients wit...
Status
Terminated
Location
Washington University
Start Date
2008-07-01
Trial ID
NCT00632827
Neuroblastoma is the most common extracranial solid tumor in childhood, wit...
Status
Completed
Location
St. Jude Children's Research Hospital
Start Date
2013-07-05
Trial ID
NCT01857934
Treatments Being Tested
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2018-05-25
Trial ID
NCT03563170
This is a phase 1b/2 study to evaluate the safety and efficacy of metronomi...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2017-12-28
Trial ID
NCT03387098
This study tests a three-phase immune treatment for people recently diagnos...
Status
Not Yet Recruiting
Location
Kara Harp Okulu (Turkish Military Academy)
Start Date
2027-01-01
Trial ID
NCT07610213
Treatments Being Tested
This study will compare the clinical activity of novel regimens (in combina...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-01-24
Trial ID
NCT03739710
Treatments Being Tested
The goal of this study is to evaluate autologous MSCs as an alternative for...
Status
Completed
Location
Stem cell therapy center,Fuzhou General Hospital
Start Date
2008-03
Trial ID
NCT00658073
Treatments Being Tested
The goal of this Phase I/II observational and interventional platform study...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-01-01
Trial ID
NCT07307053